Around the Watercooler

Key Stories from Around the Industry

 
Celsion Investor Claims CEO Tried To Bribe Him
Posted: 12/2/2011

Report shows Big Pharma's patent cliff in graphic detail
Posted: 12/2/2011

Obama Directs $50 Million to U.S. HIV Patients
Posted: 12/2/2011

Synthes, Inc. CEO to Get $52 Million in Company Sale
Posted: 12/1/2011

Caltech team offers tantalizing data on HIV 'vaccine'
Posted: 12/1/2011

CEO: Roche would consider more money-back deals
Posted: 12/1/2011

PPDI shareholders approve $3.9B sale, $21M in golden parachutes
Posted: 12/1/2011

Pfizer, GSK named in Onyx buyout gossip
Posted: 12/1/2011

Juventas agrees to all-stock buyout by Wound Management
Posted: 12/1/2011

Boston takes top spot in ranking of life sciences clusters
Posted: 11/30/2011

Affymetrix beefs up cancer research offerings in $330M eBioscience buyout
Posted: 11/30/2011

Facebook yanks URL until Mercks agree who gets it
Posted: 11/29/2011

Ex-PhRMA chief's $11.6M tops among healthcare reform lobbyists
Posted: 11/29/2011

Olympus to review business structure amid scandal
Posted: 11/29/2011

Is Wall Street to blame for lack of new drugs?
Posted: 11/28/2011

Beaker's Blog

There are only 10 legitimate life sciences hubs in the U.S.
Posted: 12/1/2011

Women in Biotech vs. Women in Life Sciences
Posted: 12/1/2011

A newer, leaner Medtronic
Posted: 12/1/2011

Former PhRMA head netted millions for Obamacare brokering
Posted: 11/29/2011

Sanofi to become top drugmaker in 2012
Posted: 11/29/2011

The tale of two Mercks and Facebook
Posted: 11/29/2011

Cool technology: Scrubbing bubbles for your bloodstream?
Posted: 11/28/2011

Lipitor no more: Pfizer set to lose biggest selling drug of all-time
Posted: 11/28/2011